Drug Free Solution, Inc. (DSOL)

Drug Free Solution Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Operating Activities

Fiscal Year	TTM	FY 2013	FY 2012
Period Ending	Feb 28, 2014	May 31, 2013	May 31, 2012
Net Income	-0.87	-0.76	-0.63
Depreciation & Amortization	0	0	0
Change in Accounts Payable	0.15	0.02	-
Change in Other Net Operating Assets	-0.02	0.04	-
Operating Cash Flow	-0.74	-0.69	-0.63
Operating Cash Flow Growth	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2013	FY 2012
Period Ending	Feb 28, 2014	May 31, 2013	May 31, 2012
Capital Expenditures	-0.03	-	-0
Investing Cash Flow	-0.03	-	-0

Financing Activities

Fiscal Year	TTM	FY 2013	FY 2012
Period Ending	Feb 28, 2014	May 31, 2013	May 31, 2012
Issuance of Common Stock	0.74	0.69	0.65
Financing Cash Flow	0.74	0.69	0.65

Net Cash Flow

Fiscal Year	TTM	FY 2013	FY 2012
Period Ending	Feb 28, 2014	May 31, 2013	May 31, 2012
Net Cash Flow	-0.03	-0.01	0.02

Free Cash Flow

Fiscal Year	TTM	FY 2013	FY 2012
Period Ending	Feb 28, 2014	May 31, 2013	May 31, 2012
Free Cash Flow	-0.76	-0.69	-0.63
Free Cash Flow Growth	-	-	-
Free Cash Flow Per Share	-0.01	-0.01	-0.01

Additional Metrics

Fiscal Year	TTM	FY 2013	FY 2012
Period Ending	Feb 28, 2014	May 31, 2013	May 31, 2012
Change in Working Capital	0.13	0.06	-

Data Source: S&P Global Market Intelligence Last updated: Feb 28, 2014

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error